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HTLV-1 Tax oncoprotein exerts pleiotropic effects on cellular regulatory systems, such as transcription and the cell cycle,
through the interaction with various cellular factors. During our search for additional cellular targets of Tax using a yeast
two-hybrid screening system, we isolated a cDNA encoding human DNA topoisomerase I. Tax was demonstrated to bind to
topoisomerase I in vitro, and the Tax-topoisomerase I complex was also detected in HTLV-1-infected T-cells by immuno-
precipitation. Furthermore, Tax inhibited the catalytic activity of topoisomerase I as measured by relaxation of supercoiled
DNA, although complete inhibition was not observed under the conditions used. The binding of topoisomerase I to DNA was
inhibited by the addition of the wild type of Tax but not by a mutant of Tax that cannot bind to topoisomerase I. Consistent
with these observations, expression of Tax induced an in vivo reduction of the covalent association of topoisomerase I with
chromosomal DNA, which accumulates in the presence of camptothecin. These results suggest that Tax has a novel potential
to affect various cellular processes such as transcription and maintenance of genomic stability, in which DNA topoisomerase
I is involved. © 2000 Academic Press
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Human T-cell leukemia virus type 1 (HTLV-1) is the
causative agent of a unique T-cell malignancy, adult
T-cell leukemia (ATL) (Poeisz et al., 1980; Yoshida et al.,
1982). The virally encoded Tax protein is thought to be a
key molecule contributing to the development of ATL,
since it has the capacity to immortalize human T cells,
transform rodent fibroblastic cells, and induce tumors in
transgenic mice (Grassmann et al., 1992; Grossman et
l., 1995; Nerenberg et al., 1987; Yamaoka et al., 1996;
oshida, 1993).
Tax has been demonstrated to be a pleiotropic effector
hich disturbs cellular regulatory processes for tran-
cription and the cell cycle. The interaction between Tax
nd specific cellular factors has been shown in these
isturbances. Tax activates or represses the expression
f a wide variety of genes through distinct promoter
equences (Yoshida, 1995). The direct targets of Tax in
hese types of dysregulation include CBP/p300 (Suzuki et
l., 1999a; Bex et al., 1998; Kwok et al., 1996), CREB,
NF-kB, SRF, and IkB (Bex et al., 1998; Fujii et al., 1992;
Hirai et al., 1994; Kwok et al., 1996; Suzuki et al., 1993,
1994; Zhao and Giam, 1992). On the other hand, Tax
enhances cell cycle progression through binding and
inhibition of cyclin-dependent kinase (CDK) inhibitors,
1 To whom correspondence and reprint requests should be ad-
ressed at present address: Banyu Tsukuba Research Institute,
-Okubo, Tsukuba, Ibaraki 300-2611, Japan. Fax: 181-298-77-2034. E-
ail: yoshimx@banyu.co.jp.
291particularly p16ink4a (Low et al., 1997; Suzuki et al.,
1996). Recently, Tax was also found to bind to the human
counterpart of Drosophila tumor suppressor protein,
hDlg, and to disturb its regulatory function in the cell
cycle (Lee et al., 1997; Suzuki et al., 1999b).
In addition, several findings suggest that Tax affects
the maintenance of genomic stability. Tax was reported
to inhibit the transcriptional activity of p53 tumor sup-
pressor protein, a guardian of the genome, leading to
disturbance of its critical checkpoint function (Akagi et
al., 1997; Mulloy et al., 1998; Pise-Masison et al., 1998;
Suzuki et al., 1999a). More importantly, it was reported
that Tax binds to HsMAD1 protein, the human counter-
part of yeast mitotic checkpoint protein, and abrogates
its function, possibly causing karyotypic abnormalities
(Jin et al., 1998). Recently, we found that expression of
Tax induced increased mutation frequency of the cellular
genome, although the mechanism has not been defined
(Miyake et al., 1999).
To identify novel cellular targets of Tax, we screened
for cellular proteins interacting with Tax using a yeast
two-hybrid method. During the screening, we identified a
cDNA encoding human DNA topoisomerase I. This en-
zyme is known to alter DNA topology by transiently
breaking one strand of DNA, passing the other strand
through the break, and finally resealing the break (Nitiss,
1998; Wang, 1996). Topoisomerase I is involved in DNA
replication and transcription to reduce tortional stress in
DNA. It is also involved in maintenance of genome sta-
bility, by participating in DNA repair and chromosome
0042-6822/00 $35.00
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292 SUZUKI ET AL.condensation. We were therefore interested in DNA to-
poisomerase I as a target for Tax to confer global effects
on cellular regulation.
In this paper, we describe Tax binding to DNA topo-
isomerase I in vitro as well as in HTLV-1-infected T-cells.
As a result of the interaction, Tax reduced the DNA-
binding activity of topoisomerase I and resulted in a
reduction of the catalytic activity of topoisomerase I.
These results suggest that Tax might abrogate cellular
regulatory processes in which DNA topoisomerase I is
involved.
RESULTS
Interaction of Tax with DNA topoisomerase I
To identify novel cellular targets of Tax, we performed
yeast two-hybrid screening using Tax protein as bait. The
yeast strain expressing Tax fused to the DNA-binding
domain of GAL4 was transformed with a library of human
cDNAs which were fused to the transcriptional activation
domain of GAL4. After screening of 1 3 106 transfor-
mants, positive clones were characterized by DNA se-
quencing. Among about 100 clones sequenced, we
found 2 independent clones encoding the C-terminal half
of human DNA topoisomerase I.
To confirm the specific interaction between Tax and
DNA topoisomerase I protein in vitro, Sf9 cells were
infected with baculovirus which expresses human DNA
topoisomerase I in the complete form, and nuclear ex-
tract was prepared. This nuclear extract was mixed with
purified recombinant Tax protein produced in Esche-
richia coli and then treated with anti-Tax antibody. The
FIG. 1. Binding of Tax protein to DNA topoisomerase I in vitro. (a) Coim
infected with baculovirus expressing DNA topoisomerase I were mixed
anti-Tax antibody. The immunoprecipitates were analyzed by Western
Coimmunoprecipitation of Tax with DNA topoisomerase I. Nuclear extra
1, 2, 4, 5) or with control baculovirus (lanes 3, 6) were mixed with purified
topoisomerase I antibody. The immunoprecipitates were analyzed by Wimmunoprecipitates were analyzed by Western blotting pwith anti-DNA topoisomerase I antibody for detection of
topoisomerase I in the immune complexes. As shown in
Fig. 1a, DNA topoisomerase I protein was coimmunopre-
cipitated with wild-type Tax, but not a with mutant Tax
d7/16, which lost most of the known activities of Tax such
as trans-activation, trans-repression, and inactivation of
nhibitors of cell cycle-dependent kinases (INK4 family)
Suzuki et al., 1994, 1996, 1999c). Reciprocal experiments
sing anti-DNA topoisomerase I antibody for immuno-
recipitation also indicated that wild-type Tax, but not
utant Tax d7/16, was coimmunoprecipitated with topo-
somerase I. These results demonstrate that Tax binds to
NA polymerase I through a specific interaction.
To demonstrate Tax binding to DNA topoisomerase I in
ivo, the nuclear extract of a HTLV-1-infected T-cell line,
ut102, was treated with anti-DNA topoisomerase I an-
ibody. The immunoprecipitates were analyzed by West-
rn blotting with anti-Tax antibody. As demonstrated in
ig. 2, antibodies to topoisomerase I immunoprecipitated
ax protein, but normal immunogloblin did not. There-
ore, we concluded that the complex of Tax and topo-
somerase I was in fact formed in T-cells naturally in-
ected with HTLV-1 (Fig. 2). In a separate control exper-
ment, d7/16 mutant was not coimmunoprecipitated with
NA topoisomerase I from cells transfected with the
7/16 expression vector (data not shown).
nhibition of DNA relaxation catalyzed by DNA
opoisomerase I
To examine whether Tax can affect the function of DNA
opoisomerase I, we measured DNA-relaxation activity of
recipitation of DNA topoisomerase I with Tax. Nuclear extracts of cells
urified Tax (lanes 1, 3) or its mutant d7/16 (lanes 2, 4), and treated with
g with anti-Tax (left) or anti-DNA topoisomerase I antibody (right). (b)
ells infected with baculovirus expressing DNA topoisomerase I (lanes
nes 1, 3, 4, 6) or its mutant d7/16 (lanes 2, 5) and treated with anti-DNA
blotting with anti-DNA topoisomerase I (left) or anti-Tax antibody (right).munop
with p
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cts of curified topoisomerase I in the presence of Tax. DNA
a
t
a
T
c
l
D
i
v
p
F
a
I
t
T
t
m
W
b
293BINDING OF Tax TO DNA TOPOISOMERASE Itopoisomerase I was purified from the nuclear extract of
baculovirus-infected Sf9 cells and preincubated with Tax
protein for 1 h at 4°C to facilitate the complex formation
when Tax is included. Then, the mixture was incubated at
37°C for 15 min with supercoiled pBR322 plasmid DNA
and then subjected to electrophoresis in 0.8% agarose
gels. As shown in Fig. 3, purified DNA topoisomerase I
changed most of the supercoiled DNA (form I) into re-
laxed DNA (form Ir). In the presence of the wild-type Tax
protein, relaxation was inhibited and nearly half of form I
DNA remained. On the other hand, Tax mutant d7/16,
which could not bind to DNA topoisomerase I, did not
exhibit a significant inhibition. The inhibitory effect of Tax
was dependent on the dose of Tax protein, but complete
inhibition was not observed even with the maximum
dose that can be applied under the experimental condi-
FIG. 2. Binding of Tax to DNA topoisomerase I in HTLV-1-infected
-cells. Nuclear extract of the HTLV-1-infected T-cell line, Hut102, was
reated with anti-DNA topoisomerase I antibody (lanes 2, 4) or normal
ouse IgG (lanes 1, 3). The immunoprecipitates were analyzed by
estern blotting with anti-DNA topoisomerase I (left) or anti-Tax anti-
ody (right).
FIG. 3. Inhibition of DNA-relaxation activity of topoisomerase I by
Tax. Purified DNA topoisomerase I was mixed with none (lane 2),
wild-type Tax (lane 3), or its mutant d7/16 (lane 4) and reacted with
supercoiled pBR322 DNA. Lane 1 shows control reaction without to-
poisomerase I. I and Ir represent the supercoiled form I DNA and the
relaxed form I DNA, respectively.tions used (data not shown). These results indicate that
Tax can inhibit DNA topoisomerase I in the DNA-relax-
ation reaction probably through direct binding to topo-
isomerase I.
Inhibition of DNA binding of topoisomerase I
DNA relaxation catalyzed by DNA topoisomerase I can
be divided into four steps: (i) DNA binding of topoisom-
erase I, (ii) single-strand cleavage, (iii) strand passage,
and (iv) DNA resealing (Nitiss, 1998; Wang, 1996). To
analyze which step is inhibited by Tax, we first examined
the effect of Tax on the formation of a covalent linkage of
topoisomerase I to DNA by strand scission of the DNA,
which is termed cleavable complex. The cleavable com-
plex is known to accumulate in the presence of camp-
tothecin (CPT), a topoisomerase I-specific inhibitor drug
(Chen and Liu, 1994; Hsiang et al., 1985). After the relax-
tion reaction in the presence of CPT, the mixture was
reated with sodium dodecyl sulfate (SDS) and protein-
se K to remove covalently linked proteins from DNA.
he DNA was analyzed by agarose gel electrophoresis
ontaining 0.5 mg/ml ethidium bromide, where the re-
axed DNA (form I) is distinguished from nicked circular
NA (form II). As shown in Fig. 4, DNA topoisomerase I
nduced the relaxation of supercoiled DNA (form I), con-
erting it into form Ir DNA, and the wild type of Tax
rotein inhibited the relaxation of DNA as expected from
ig. 3. Figure 4 also demonstrated that Tax did not induce
ccumulation of intermediate nicked circular DNA (form
I). In the case of CPT, a topoisomerase-specific inhibitor,
he intermediate nicked circular DNA (form II), which
FIG. 4. Detection of strand breaks of DNA in the presence of Tax
and/or CPT. Purified DNA topoisomerase I was mixed with none (lane
2), wild-type Tax (lane 3), or CPT (lane 4) and reacted with supercoiled
pBR322 DNA. Lane 1 shows control reaction without topoisomerase I.
I and Ir are described in Fig. 3. II indicates the position of nicked
circular DNA (form II).
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294 SUZUKI ET AL.represents the cleavable complex, accumulated. These
results indicate that Tax inhibits the reaction catalyzed by
topoisomerase I before the single-strand cleavage step.
Thus the site of Tax action is distinct from that of CPT
which stabilizes the reaction intermediate, the cleavable
complex.
Next, we examined the effect of Tax on the DNA-
binding activity of topoisomerase I by the filter-binding
assay. DNA topoisomerase I and 32P-labeled pBR322
DNA were incubated with or without Tax, and the incu-
bation mixtures were filtered through nitrocellulose
membranes. The DNA-protein complexes trapped on the
filter were estimated by the radioactivity. In this filter
assay, Tax binding to DNA was very weak corresponding
to less than 5% of that of topoisomerase I, thus a vast
majority of the DNA trapped on the filter is mediated by
the binding of topoisomerase I to DNA. As shown in Fig.
5, the wild type of Tax led to a significant decrease of
DNA binding of topoisomerase I in a dose-dependent
manner. However, Tax mutant d7/16, which could not
bind to topoisomerase I, had no effect. This result indi-
cates that Tax inhibits the DNA binding of topoisomerase
I, which is the first step of the reaction catalyzed by
topoisomerase I.
In vivo effect of Tax on DNA binding
of topoisomerase I
To demonstrate that Tax affects DNA topoisomerase I
activity in vivo, we performed the following experiment
FIG. 5. Effect of Tax on DNA-binding activity of topoisomerase I.
32P-end-labeled pBR322 DNA and DNA topoisomerase I were incu-
ated with Tax (closed circle) or its mutant d7/16 (open circle) and
iltered through nitrocellulose membranes. The bound radioactivity was
easured by a liquid scintillation counter and the percentage bound
as calculated. Each point shows the average of triplicate reactions.
ars indicate SD.called band depletion assay. It is known that CPT treat-
ment of cells induces accumulation of the complex of
DNA topoisomerase I covalently linked to chromosomal
DNA (Chen and Liu, 1994; Hsiang and Liu, 1988). When
the cell lysate was subjected to immunoblotting with
anti-DNA topoisomerase I antibody, the band of topo-
isomerase I disappeared in the presence of CPT, be-
cause the vast majority of topoisomerase I binds to DNA
and the covalently linked complex with DNA is too large
to enter the gel. If Tax inhibits DNA binding of topoisom-
erase I in vivo, it is predicted that CPT-induced band
depletion is incomplete in cells expressing Tax protein.
To test this hypothesis, HeLa cells were infected with a
recombinant adenovirus vector for the expression of Tax.
After cultivation for 36 h, the cells were treated with CPT
for 30 min. Then whole cell extracts were analyzed by
immunoblotting with anti-DNA topoisomerase I antibody
to compare free topoisomerase I. As shown in Fig. 6,
treatment of HeLa cells infected with control adenovirus
vector (Ad-control) with 25 mM CPT caused a complete
disappearance of free topoisomerase I protein (lane 3).
On the other hand, the same treatment of HeLa cells
infected with Tax-expressing adenovirus (Ad-Tax) caused
only partial reduction of topoisomerase I protein (lane 6),
although the untreated cells expressed almost the same
level of free Topoisomerase I (lanes 1 and 4). These
results indicate that CPT-induced band depletion of to-
poisomerase I was significantly inhibited by Tax protein.
These observations indicate that some fraction of topo-
isomerase I is prevented from binding to chromosomal
DNA in Tax-expressing cells. The level of Tax expression
in the adenovirus-infected cells was lower than that in
HTLV-1-infected cell lines, while the levels of topoisom-
erase I were similar to each other. Therefore, we con-
FIG. 6. Inhibition of CPT-induced accumulation of covalently linked
topoisomerase I-DNA complex, a cleavable complex, resulting in in-
creasing the free form of topoisomerase I. HeLa cells were infected
with adenovirus vector expressing Tax (lanes 4–6) or control virus
(lanes 1–3). After cultivation for 36 h, cells were treated with CPT at the
indicated concentrations for 30 min. Then whole cell extracts were
prepared and analyzed by Western blotting with anti-DNA topoisomer-
ase I antibody.cluded that Tax in fact functions to inhibit the DNA-
295BINDING OF Tax TO DNA TOPOISOMERASE Ibinding step of topoisomerase I in T cells naturally in-
fected with HTLV-1.
DISCUSSION
In this study, we demonstrated that Tax binds to DNA
topoisomerase I in vitro and in vivo. The binding of Tax to
topoisomerase I inhibits the DNA binding of topoisom-
erase I; thus, the functions of topoisomerase I after DNA
binding are all restricted. Therefore, topoisomerase I is a
novel cellular target for Tax to affect a wide variety of
cellular regulation.
Topoisomerase I fragments isolated by the yeast two-
hybrid assay were the C-terminal half of DNA topoisomer-
ase I, indicating that the Tax-binding domain of topoisom-
erase I is the C-terminal half. This domain of topoisomerase
I is also responsible for DNA-binding and catalytic activity
for DNA relaxation (Wang, 1996). Therefore, the inhibition of
DNA-binding and DNA-relaxation activity of topoisomerase
I by Tax protein may be explained by the possible occu-
pancy of the active domain of the enzyme. However, the
activity of topoisomerase I was not completely inhibited by
Tax under the conditions used in vitro. We do not know the
exact reason for the partial inhibition, but it might be ex-
plained by weak binding of Tax to topoisomerase I or by the
limited amount of Tax protein in the reaction. Partial inhibi-
tion of topoisomerase I by Tax was also observed in vivo;
the band depletion of topoisomerase I (Fig. 6) was partially
inhibited by expression of Tax, clearly suggesting that the
interaction of Tax and topoisomerase I also exists in vivo.
DNA topoisomerase I is known to be an essential gene in
higher eukaryotes. A gene knockout study showed that
topoisomerase I is required both for embryonic develop-
ment and for maintenance of viability of somatic cells
(Morham et al., 1996). Therefore, the partial inhibition by Tax
might be a significant and effective strategy for HTLV-1 to
disturb multiple cellular regulatory functions through DNA
topoisomerase I, but keep cells viable.
A recent paper describes that UV irradiation enhanced
covalent linkage of topoisomerase I to chromosomal
DNA in irradiated cells (Subramanian et al., 1998). Fur-
thermore, repair-deficient cells were compromised in
their ability to recruit topoisomerase I onto DNA. Since
such complex formation between DNA and topoisomer-
ase I is detected at UV doses that result in relatively little
cell killing, these data suggest a role of topoisomerase I
in the DNA repair process. This notion is strongly sup-
ported by another finding that p53 tumor suppressor
protein interacts with topoisomerase I and increases its
catalytic activity (Gobert et al., 1996), since p53 plays a
central role in the cellular response to DNA damage. Tax
binding to topoisomerase I observed in this paper might
disturb its function in the DNA repair process against
DNA damage. This possibility is worth examining in
order to understand the mechanism of the genomic sta-
bility of HTLV-1-infected T-cells, possibly contributing tomalignant transformation. It is also notable that Tax on-
coprotein inhibits the activity of topoisomerase I, which
is the opposite effect of that induced by p53 tumor
suppressor protein.
It is reported that DNA topoisomerase I also plays a
role in the mitotic phase. In Saccharomyces cerevisiae,
topoisomerase I and related TRF4 protein were shown to
participate in mitotic chromosome condensation (Cas-
tano et al., 1996). The double mutant of these genes
failed to establish chromosome condensation, and its
defect was sensed by a MAD1-dependent spindle as-
sembly checkpoint, resulting in mitotic arrest. Also, in
higher eukaryotes, topoisomerase I is involved in chro-
mosome condensation cooperating with the 13S conden-
sin complex (Kimura and Hirano, 1997). Recently, Jin et al.
reported that Tax bound to HsMAD1 protein, the human
counterpart of yeast MAD1, and abrogated its function,
which might explain Tax-induced mitotic abnormalities
(Jin et al., 1998; Semmes et al., 1996). The present ob-
servations, therefore, suggest that DNA topoisomerase I
could be another new target molecule of Tax in mitotic
processes. Further analyses on the functional effects of
Tax on topoisomerase I would shed light on understand-
ing the effect of Tax on mitotic regulation.
Inhibition of DNA topoisomerase I activity has been
well described as the action of several classes of anti-
cancer drugs including CPT (Chen and Liu, 1994; Hsiang
et al., 1985; Hsiang and Liu, 1988). These drugs prevent
the topoisomerase I enzyme reaction by stabilizing en-
zyme-linked DNA single-strand breaks. We found that
Tax inhibits DNA binding of topoisomerase I before sin-
gle-strand cleavage and partially disturbs the CPT-in-
duced covalent association of topoisomerase I with
DNA. These results suggest that expression of Tax might
confer drug resistance properties on cells. This hypoth-
esis would be interesting to examine.
In the present study, Tax was found to interact with
DNA topoisomerase I and inhibit its catalytic activity. It is
expected that Tax affects various cellular processes me-
diated by topoisomerase I. However, in mammalian cells,
the precise roles of topoisomerase I in most processes,
such as transcription and replication, have not been
clarified. Furthermore, one may argue that the observed
effect of Tax in vivo on topoisomerase I might be an
indirect result of the pleiotropic functions of Tax protein.
Therefore, further investigation will be required for un-
derstanding the exact effects of Tax through topoisom-
erase I on cellular regulation and on the pathogenesis of
HTLV-1.
MATERIALS AND METHODS
Cells, plasmids, proteins, and antibodies
Hut102, a human T-cell line infected with HTLV-1 was
maintained in RPMI 1640 supplemented with 10% fetal
calf serum (FCS). The HeLa cell line was maintained in
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296 SUZUKI ET AL.Dulbecco’s modified Eagle medium (DMEM) supple-
mented with 10% FCS. The Sf9 cell line was maintained
in TC-100 insect medium supplemented with 10% calf
serum.
For the yeast two-hybrid assay, the Tax coding se-
quence was cloned into pGBT9 plasmid which ex-
presses the GAL4 DNA-binding domain (Clonetech). To
construct a recombinant adenovirus vector, the coding
sequence of Tax or lacZ was blunt-ended and ligated into
the SwaI site of a cosmid, pAdex1CAwt, donated by Dr.
Izumu Saito, University of Tokyo. The recombinant ade-
novirus was prepared according to the procedure previ-
ously described (Kanegae et al., 1994; Miyake et al.,
1996; Niwa et al., 1991).
To obtain DNA topoisomerase I protein, Sf9 cells were
infected with the recombinant baculovirus carrying hu-
man DNA topoisomerase I cDNA. Cells were harvested
at 3 days after infection and lysed. The nuclear pellets
were extracted with a buffer containing 0.5% NP-40 and
extraction of nuclei was performed with 0.4 M NaCl
(Suzuki et al., 1994). Purification of DNA topoisomerase I
was performed as described previously with some mod-
ifications (Ishii et al., 1983). Recombinant Tax protein and
its mutant d7/16, which has a sequence alteration at
amino acids 234–245, LLPFHATLTTPG to PSL, were pro-
duced in E. coli and purified as described previously
(Suzuki et al., 1994).
Anti-Tax antibody against the C-terminus of Tax protein
was reported previously (Suzuki et al., 1993). Mouse
monoclonal antibody T14C against human DNA topo-
isomerase I was provided by Dr. Yoshikazu Sugimoto,
Japanese Foundation for Cancer Research (Sugimoto et
al., 1990).
Yeast two-hybrid screening
The two-hybrid screen was performed with the yeast
HF7c reporter strain (Clontech) including pGBT-Tax plas-
mid. Transformation of this strain by a library of human
cDNA fused to GAL4 activation domain was performed
by the lithium acetate method. The cDNAs originated
from mRNA of human 293T cell line and were inserted
into pGAD-GH plasmid (Clontech). After transformation,
yeast cells were plated on synthetic medium lacking
leucine, tryptophan, and histidine and incubated at 30°C
for 5 days. A total of 1.0 3 106 transformants was
creened. About one hundred clones growing on selec-
ion plates were tested for b-galactosidase expression
y the filter-assay technique. Total yeast DNA was iso-
ated from positive colonies in the b-galactosidase assay
and transformed into leuB-HB101 E. coli strain. The
GAD plasmids isolated from the recombinant colonies
elected under minimal medium containing ampicillin
ere analyzed by DNA sequencing and retransformed
ith pGBT9 or pGBT-Tax into the HF7c yeast strain to
liminate false positives.Immunoprecipitation and Western blotting
Nuclear extract of baculovirus-infected Sf9 cells or
Hut102 cells was prepared and diluted with NETG buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Nonidet
P-40, 1 mM EDTA, 0.25% gelatin, 0.02% sodium azide)
and treated with anti-Tax antibody or anti-DNA topoisom-
erase I antibody. The immune complexes were collected
on protein A or G Sepharose CL4B (Pharmacia) and
separated in SDS-polyacrylamide gel followed by West-
ern blotting. The proteins were transferred to an Immo-
bilon membrane filter (Millipore) and probed with each
antibody. Detection was performed with the enhanced
chemiluminescence system (Amersham).
DNA relaxation and cleavable complex assay
DNA-relaxation activity of DNA topoisomerase I was
assayed essentially as described previously (Hsiang et
al., 1985). The reaction mixture consisted of a total vol-
ume of 20 ml containing 0.2 mg supercoiled pBR322 DNA,
50 mM NaCl, 50 mM Tris-HCl (pH 7.5), 10% glycerol, 30
mg/ml BSA, 0.5 mM EDTA, 0.5 mM DTT, and DNA topo-
isomerase I (2 ng) with or without Tax (10 ng). DNA
topoisomerase I was preincubated with Tax protein for
1 h at 4°C to facilitate the complex formation when Tax is
included. Then, the mixture was incubated at 37°C for 15
min and loaded on a 0.8% agarose gel. Gels were
stained with ethidium bromide and photographed under
UV light.
Cleavable complex formation between DNA and topo-
isomerase I in the presence of campthothesin or Tax was
assayed as follows. The reaction mixture consisted of a
total volume of 40 ml containing 0.2 mg of supercoiled
BR322 DNA, DNA topoisomerase I (10 ng) with or with-
ut 5 mM CPT, or Tax (50 ng). Then SDS and proteinase
were added to a final concentration of 1% and 500
mg/ml, respectively, and the mixture was incubated at
50°C for 1 h. The aqueous phase was recovered by
phenol/chloroform extraction and loaded on a 0.8% aga-
rose gel containing 0.5 mg/ml ethidium bromide.
Filter-binding assay
Five nanograms of DNA topoisomerase I was prein-
cubated with varying amounts of Tax protein for 1 h at
4°C to facilitate the complex formation when Tax is
included. Then, the mixture in 40 ml binding buffer (10
M Tris-HCl, pH 7.5, 20 mg/ml BSA, and 0.1 mM EDTA)
was incubated for 10 min at 0°C with 32P-end-labeled
pBR322 DNA (1 ng) and then filtered through a nitrocel-
lulose membrane (0.2 mm). The DNA-protein complexes
trapped were washed with 3 ml binding buffer. The
bound radioactivity was measured by a liquid scintilla-
tion counter.
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